| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Analysis on herbal medicines utilized for treatment of COVID-19
|
Luo, Lu
|
|
|
10 |
7 |
p. 1192-1204
|
artikel
|
| 2 |
Bioactive natural compounds against human coronaviruses: a review and perspective
|
Xian, Yanfang
|
|
|
10 |
7 |
p. 1163-1174
|
artikel
|
| 3 |
Combating COVID-19 with integrated traditional Chinese and Western medicine in China
|
Ni, Liqiang
|
|
|
10 |
7 |
p. 1149-1162
|
artikel
|
| 4 |
Cover Story
|
|
|
|
10 |
7 |
p. ix
|
artikel
|
| 5 |
Crystal structure of SARS-CoV-2 nucleocapsid protein RNA binding domain reveals potential unique drug targeting sites
|
Kang, Sisi
|
|
|
10 |
7 |
p. 1228-1238
|
artikel
|
| 6 |
Design of drug-like hepsin inhibitors against prostate cancer and kidney stones
|
Blay, Vincent
|
|
|
10 |
7 |
p. 1309-1320
|
artikel
|
| 7 |
Dose selection of chloroquine phosphate for treatment of COVID-19 based on a physiologically based pharmacokinetic model
|
Cui, Cheng
|
|
|
10 |
7 |
p. 1216-1227
|
artikel
|
| 8 |
D3Targets-2019-nCoV: a webserver for predicting drug targets and for multi-target and multi-site based virtual screening against COVID-19
|
Shi, Yulong
|
|
|
10 |
7 |
p. 1239-1248
|
artikel
|
| 9 |
Editorial of Special Column “Research on Emerging COVID-19 (Target, Mechanism, and Therapeutics)”
|
Luo, Hai-Bin
|
|
|
10 |
7 |
p. 1146-1148
|
artikel
|
| 10 |
Editor Profiles: Guest Editors of Special Column “Research on Emerging COVID-19 (Target, Mechanism, and Therapeutics)”
|
|
|
|
10 |
7 |
p. 1145
|
artikel
|
| 11 |
Efficient drug and gene delivery to liver fibrosis: rationale, recent advances, and perspectives
|
Mahdinloo, Somayeh
|
|
|
10 |
7 |
p. 1279-1293
|
artikel
|
| 12 |
Evaluation of 124I-JS001 for hPD1 immuno-PET imaging using sarcoma cell homografts in humanized mice
|
Huang, Haifeng
|
|
|
10 |
7 |
p. 1321-1330
|
artikel
|
| 13 |
Evodiamine-inspired dual inhibitors of histone deacetylase 1 (HDAC1) and topoisomerase 2 (TOP2) with potent antitumor activity
|
Huang, Yahui
|
|
|
10 |
7 |
p. 1294-1308
|
artikel
|
| 14 |
Highly pathogenic coronaviruses: thrusting vaccine development in the spotlight
|
He, Chunting
|
|
|
10 |
7 |
p. 1175-1191
|
artikel
|
| 15 |
Letter to the editor: Anti-RAS drugs and SARS-CoV-2 infection
|
Bian, Jingwei
|
|
|
10 |
7 |
p. 1251-1252
|
artikel
|
| 16 |
Letter to the editor: Comment on GLP-1-based drugs and COVID-19 treatment
|
Jin, Tianru
|
|
|
10 |
7 |
p. 1249-1250
|
artikel
|
| 17 |
Novel approach for real-time monitoring of carrier-based DPIs delivery process via pulmonary route based on modular modified Sympatec HELOS
|
Zhang, Xuejuan
|
|
|
10 |
7 |
p. 1331-1346
|
artikel
|
| 18 |
Potential therapeutic effects of dipyridamole in the severely ill patients with COVID-19
|
Liu, Xiaoyan
|
|
|
10 |
7 |
p. 1205-1215
|
artikel
|
| 19 |
Small-molecule MDM2/X inhibitors and PROTAC degraders for cancer therapy: advances and perspectives
|
Fang, Yuan
|
|
|
10 |
7 |
p. 1253-1278
|
artikel
|
| 20 |
Table of Contents
|
|
|
|
10 |
7 |
p. iii-viii
|
artikel
|
Tijdschrift beschrijving